The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19

COVID Clinical Trial

Official title:

The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 at Emergency Department

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04399681
• Other study ID #: KSSEAH--
• Status: Recruiting
• Phase: N/A
• Start date: May 10, 2020
• Est. completion date: September 10, 2020

Study information

• Verified date: May 2020
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: Ramazan Guven
• Phone: +902124041500
• Email: drramazanguven[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Description:

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 10, 2020
• Est. primary completion date: August 10, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients with an informed consent

• Admission to emergency department with symptoms or signs of COVID-19

Exclusion Criteria:

• Absence of informed consent

• Patients under age of 18

• Presence of acute coronary syndrome

• Presence of chronic lung disease

• Pregnancy

• Presence of trauma

• Patients with a diagnosis of malignancy

Related Conditions & MeSH terms

• COVID
• Pneumonia
• Pneumonia, Viral

Intervention

Device:
• Bedside lung ultrasound
Point of care ultrasound will be used as bedside lung ultrasound to determine the patients if they have a COVID-19 pneumonia.

Locations

Country	Name	City	State
Turkey	Istanbul Kanuni Sultan Suleyman Training and Research Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Presence of viral pneumonia caused by COVID 19	Efficacy of POCUS on diagnosis of viral pneumonia caused by COVID 19	3 months